“Sales/PAT at BCCL has grown at a CAGR of 5%/37% respectively over FY23-25. BCCL clocked EBITDA margins of 12.7% in FY25 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback